Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
33%
Apolipoprotein
16%
Apolipoprotein E
41%
Basal Ganglia
29%
Blood Plasma
16%
Cerebellum
8%
Cerebrovascular Accident
6%
Cerebrovascular Disease
16%
Cholinergic
16%
Cognitive Function
7%
Enhancer Region
11%
Frontal Lobe
5%
Mild Cognitive Impairment
9%
Mindfulness
19%
Modafinil
16%
Nasal Spray
9%
Neurodegenerative Disorder
8%
Neuropsychiatric Symptom
16%
Parasympathomimetic Drug
7%
Parkinson's Disease
20%
Placebo
26%
positron emission tomographic scan
14%
Prospective Memory
36%
Putamen
16%
Repressor
16%
Medicine and Dentistry
Alzheimer's Disease
50%
Amyloid Protein
33%
Apolipoprotein
16%
Apolipoprotein E
19%
Biological Marker
16%
Brain Region
16%
Breathing
16%
Cerebrovascular Disease
16%
Combination Therapy
16%
Coronary Risk
20%
Degenerative Disease
5%
Diseases
8%
Ethyl(phenyl)malonamide
16%
Genetic Risk
16%
High-Risk Population
16%
Magnetic Resonance Imaging
6%
Neuropsychiatric Symptom
16%
Personal Experience
16%
Personalized Medicine
16%
Pittsburgh Compound B
30%
Positron Emission Tomography
9%
Repressor Gene
16%
Psychology
Alzheimer's Disease
83%
Basal Ganglion
33%
Behavioral Intervention
16%
Cognitive effects
16%
Cognitive Function
22%
High-Risk Population
16%
Mindfulness
21%
Mood
33%
Motor Skills
5%
Negative Thinking
10%
Prospective Memory
50%
Psychological Intervention
16%
Skill Acquisition
5%
Working Memory
16%
